) [153]. This process is at the moment not scalable because it relies on costly startup substrates which can be employed to supply psilocybin in much less expensive chemical synthesis methodologies. A methodology for de novo production of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,This heightened sensory notion is likely due